Bioelectrical Stimulation for the Reduction of Inflammation in Inflammatory Bowel Disease

• Main Authors: Ryan Marshall, Ian Taylor, Christopher Lahr, Thomas L. Abell, Ingrid Espinoza, Nitin K. Gupta, Christian R. Gomez
• Format: Article
• Language: English
• Published: SAGE Publishing 2015-08-01
• Series: Clinical Medicine Insights: Gastroenterology
• Online Access: https://doi.org/10.4137/CGast.S31779

Crohn's disease and ulcerative colitis are the primary inflammatory bowel diseases (IBDs) affecting the gastrointestinal tract. The current therapy aims at decreasing inflammation and reducing symptoms. This typically requires immune suppression by steroids, thiopurines, methotrexate, or tumor necrosis factor inhibitors. Patients may be unreceptive to medical therapy, and some may discontinue the treatment due to adverse effects. Noninvasive, transcutaneous vagus nerve stimulation (VNS) is currently used as a treatment for depression and epilepsy, and it is being investigated for the treatment of conditions such as multiple sclerosis, migraines, and Alzheimer's disease. Recent studies have demonstrated the importance of splenic and vagus nerve functions in the inflammatory process through the production of certain cytokines. We hypothesize that using transcutaneous VNS via the auricular afferent branch could achieve a selective anti-inflammatory effect on the intestinal wall. This review examines the possibility of using vagal stimulators as a therapy for IBD. This could open the door to novel treatments for numerous vagally mediated diseases characterized by poor responses to current therapies.